Ozagrel

Ozagrel
Systematic (IUPAC) name

(2E)-3-[4-(1H-imidazol-1-ylmethyl)phenyl]acrylic acid
Clinical data
AHFS/Drugs.com	International Drug Names
Legal status	℞ (Prescription only)
Routes of administration	Oral
Identifiers
CAS Registry Number	82571-53-7^Y
ATC code	None
PubChem	CID 5282440
ChemSpider	4445594^N
UNII	L256JB984D^N
KEGG	D08327^Y
ChEMBL	CHEMBL11662^N
Chemical data
Formula	C₁₃H₁₂N₂O₂
Molecular mass	228.24 g/mol
SMILES C1=CC(=CC=C1CN2C=CN=C2)/C=C/C(=O)O
InChI InChI=1S/C13H12N2O2/c16-13(17)6-5-11-1-3-12(4-2-11)9-15-8-7-14-10-15/h1-8,10H,9H2,(H,16,17)/b6-5+ ^N Key:SHZKQBHERIJWAO-AATRIKPKSA-N ^N
N (what is this?) (verify)

Ozagrel (INN) is an antiplatelet agent working as a thromboxane A2 synthesis inhibitor.^[1]

References

↑ Loo MH, Egan D, Vaughan ED, Marion D, Felsen D, Weisman S (March 1987). "The effect of the thromboxane A2 synthesis inhibitor OKY-046 on renal function in rabbits following release of unilateral ureteral obstruction". J. Urol. 137 (3): 571–6. PMID 3820396.